Two Sigma Securities’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50K Buy
+12,793
New +$62.8K ﹤0.01% 1407
2023
Q2
– Sell
-10,922
Closed -$62.3K – 3225
2023
Q1
$62.3K Buy
+10,922
New +$66.6K ﹤0.01% 2259

Other funds holding PRLD

Two Sigma Securities's PRLD Position: Q3 2026 in Review

Two Sigma Securities opened a new position in Prelude Therapeutics (PRLD) in Q3 2026: 12,793 shares worth $50K. The stake represents ﹤0.01% of the portfolio and ranks #1407 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in PRLD as recently as Q1 2023.

Two Sigma Securities first reported a position in PRLD in Q1 2023 and has held it in 2 quarters since. The position peaked at $62.3K in Q1 2023. 92 funds tracked by Wall St. Rank hold PRLD as of Q3 2026.

  • Two Sigma Securities held 12,793 shares of Prelude Therapeutics worth $50K as of Q3 2026.
  • Prelude Therapeutics was a new Two Sigma Securities position in Q3 2026.
  • Prelude Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q3 2026, its #1407 holding.
  • Two Sigma Securities first reported a position in Prelude Therapeutics in Q1 2023 and has held it in 2 quarters since.
  • Two Sigma Securities's Prelude Therapeutics position peaked at $62.3K in Q1 2023.
  • 92 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q3 2026.

Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.